Overview
Cortec Neuro designs fully implantable neural interfaces and electrode arrays for both research and clinical applications. Their systems support long-term chronic recording and stimulation in freely moving subjects.
Cortec Neuro is a neurotechnology company headquartered in Aachen, Germany, specializing in the design and development of fully implantable neural interfaces and electrode arrays. Their core technology enables both research institutions and clinical applications to conduct long-term, chronic neural recording and stimulation studies in freely moving subjects. By eliminating the constraints of tethered systems, Cortec Neuro's solutions allow researchers and clinicians to capture neural data in naturalistic behavioral settings, significantly expanding the scope of what can be studied and treated in neuroscience and medicine.
The company has established itself as a key innovator in the brain-computer interface space through the development of advanced implantable systems that prioritize biocompatibility, longevity, and signal fidelity. Their electrode arrays and neural interfaces are engineered to maintain stable performance over extended periods, addressing one of the critical challenges in neurotechnology where electrode degradation and immune responses have historically limited recording windows. This technical achievement has positioned Cortec Neuro as a trusted provider for both preclinical neuroscience research and emerging clinical applications seeking reliable neural interfacing solutions.
Cortec Neuro's contributions are significant to the broader neurotech industry because their fully implantable technology bridges a critical gap between laboratory research and clinical translation. By enabling chronic recording and stimulation in freely moving subjects, they facilitate more translatable research outcomes and support the development of next-generation brain-computer interfaces for applications ranging from movement restoration to sensory augmentation. Their work advances the technical foundation upon which future clinical therapies and neuroscience discoveries will be built, making them an important player in accelerating the maturation of the BCI field.
More in Brain-Computer Interfaces
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →